How Monitoring Has Changed for Americans
For decades, the standard routine looked the same: a small lancing device, a drop of blood, a test strip, and a number within seconds. Traditional glucometers like the OneTouch Verio Flex, Accu-Chek Guide, and CONTOUR NEXT remain widely available at pharmacies across the country, with many meters retailing in the $20 to $35 range at chains like CVS, Walgreens, and Walmart. They are accurate, affordable, and require no prescription.
What has changed is the rise of continuous glucose monitors, or CGMs. A CGM places a tiny sensor just beneath the skin, usually on the upper arm, and reads glucose from the interstitial fluid rather than directly from blood. Instead of a single snapshot, you get a rolling picture of your levels throughout the day, complete with trend arrows and alerts when things swing too high or too low.
The appeal is obvious for busy parents in Texas juggling school runs and soccer practice, for retirees in Florida who travel between seasonal homes, and for the growing number of adults in their thirties and forties who simply want to understand how their meals affect their energy. The technology is no longer reserved for Type 1 diabetes care; it has become a mainstream tool for metabolic health.
What You Need to Know Before Choosing a Device
Traditional Meters Still Have a Place
If you manage Type 2 diabetes through diet and exercise, or you only need periodic checks before and after meals, a standard glucometer often does everything you need. Test strips are the ongoing cost to watch, and many pharmacy chains offer store-brand strips that work with popular meters at a more affordable price. Meters themselves are cheap, and you can buy them over the counter without a doctor's visit.
The main limitation is that a finger-stick only captures one moment. If your levels drop at 2 a.m., nobody knows until morning. That blind spot is exactly where CGMs shine.
CGMs: The Big Picture
Continuous monitors come in two broad categories in the US market: prescription devices and over-the-counter models.
On the prescription side, the Dexcom G7 and FreeStyle Libre 3 lead the pack. The G7 offers a 30-minute warm-up, the fastest in its class, and works with Medicare and most commercial insurance plans. The FreeStyle Libre 3 is known for strong accuracy and longer sensor wear, making it a favorite among people who want fewer sensor changes.
For those who do not use insulin and want to skip the prescription process entirely, over-the-counter CGMs changed the game. The Dexcom Stelo was the first FDA-cleared OTC CGM, sold at CVS, Walmart, Target, and online without a doctor's appointment. Abbott followed with the Libre Rio. Both are designed for adults with Type 2 diabetes not on insulin, or for anyone curious about how food and exercise affect their glucose.
A quick comparison of the main options:
| Device Type | Example | Typical Cost | Best For | Pros | Cons |
|---|
| Traditional Meter | OneTouch Verio Flex | $20–$35 for meter; strips ongoing | Budget-conscious users, occasional checks | Highly accurate, no prescription, low upfront cost | No trend data, requires finger pricks |
| Prescription CGM | Dexcom G7 | Roughly $350–$400 per month without insurance | Insulin users, Type 1, those needing hypoglycemia alerts | Real-time alerts, pump integration, fast warm-up | Higher cost, requires prescription and insurance coordination |
| Prescription CGM | FreeStyle Libre 3 Plus | Around $160 per month without insurance | Cost-conscious insulin users | Good accuracy, longer sensor wear, lower price | Still needs a prescription |
| OTC CGM | Dexcom Stelo | About $99 per month | Type 2 not on insulin, wellness tracking | No prescription, available at major retailers | No hypoglycemia alerts for dangerous lows |
| OTC CGM | Abbott Libre Rio | About $89–$99 per month | Type 2 not on insulin, metabolic health | Most affordable CGM option | Same limitation on low alerts |
Navigating Insurance, Medicare, and Out-of-Pocket Costs
The single biggest question most Americans ask is whether their insurance will cover a CGM. The answer depends on your diagnosis and treatment plan.
Commercial insurance plans typically cover prescription CGMs when your doctor documents a medical need, which usually means you use insulin or have a history of problematic low blood sugar. Medicare has expanded its criteria in recent years. Coverage now extends beyond insulin users to include beneficiaries with documented Level 2 or Level 3 hypoglycemia, and even cases of needle phobia that interfere with proper monitoring. A mandatory follow-up visit with your healthcare provider every six months keeps the coverage active.
For people without insurance or with high deductibles, the landscape has improved considerably. The OTC Stelo and Libre Rio removed the prescription barrier entirely, and manufacturer savings programs on the Dexcom website and Abbott's myfreestyle portal can reduce out-of-pocket costs for qualifying patients. If you are uninsured and need a prescription-grade CGM, the FreeStyle Libre 3 Plus at roughly $160 per month is the more economical choice compared with the G7.
Medicare beneficiaries under Part D also benefit from a new annual out-of-pocket cap on prescription drug costs, which can meaningfully limit what you pay for CGM supplies in a given year.
Practical Steps to Get Started
Start by having an honest conversation with your doctor about your monitoring goals. If you wake up with morning headaches and wonder whether your blood sugar is dipping overnight, a CGM with trend data may be worth the investment. If you only need reassurance after a heavy meal, a traditional meter may be plenty.
Check your pharmacy benefits first. Call the number on the back of your insurance card and ask specifically whether continuous glucose monitors are covered, what your copay would be, and whether prior authorization is required. This five-minute call can save you hundreds of dollars.
If you are going the OTC route, prices vary slightly by retailer. The Stelo and Libre Rio hover around $89 to $99 per month at most chains, and seasonal promotions occasionally bring that number lower. Compare prices at your local CVS, Walgreens, and Walmart before committing.
For seniors, ask your provider about a Certificate of Medical Necessity and confirm the specific brand covered under your Medicare plan. The six-month follow-up requirement is worth putting on your calendar now, not when the reminder letter arrives.
Local resources can make the transition smoother. Diabetes education programs at major hospital systems in cities like Houston, Chicago, and Atlanta often include hands-on sessions where you can try different devices before purchasing. Many community health centers offer sliding-scale support for monitoring supplies, and state diabetes coalitions publish lists of certified educators who can help you interpret your numbers.
Making Monitoring Work for the Long Run
No single device fits everyone. A young professional in New York might prefer the OTC Stelo for general wellness tracking, while a retired veteran in Phoenix managing insulin needs the alert features of the Dexcom G7. The right choice depends on your medical needs, your budget, and how much data you actually want to see.
One pattern emerges across all user types: people who monitor consistently manage their numbers better. Sarah from Ohio, a Type 2 patient who switched from finger-sticks to a Libre sensor, told her clinic she finally understood why her afternoon energy crashed after lunch. James in California, a self-described data enthusiast, uses his Stelo to fine-tune his pre-workout snacks. These are not extraordinary cases; they are ordinary people who found a monitoring rhythm that stuck.
Start small. If you are new to CGMs, try one month and see whether the trend data changes how you eat, sleep, or move. If you stay with a traditional meter, set a phone reminder for the same time each day so testing becomes a habit rather than an interruption. Whatever path you choose, the goal is not perfection. It is a clearer picture of your own body, one reading at a time.
研究の知恵